Drug-eluting versus bare-metal stents for treating saphenous vein grafts
- 1 October 2009
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 158 (4) , 637-643
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A Randomized Controlled Trial of a Paclitaxel-Eluting Stent Versus a Similar Bare-Metal Stent in Saphenous Vein Graft LesionsJACC, 2009
- Use of Drug‐Eluting Stents in Saphenous Vein Aortocoronary Bypass Graft Lesions: A Critical AppraisalJournal of Interventional Cardiology, 2008
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary InterventionJACC, 2008
- Drug-Eluting Stent Update 2007Circulation, 2007
- Increased Late Mortality After Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein GraftsJACC, 2007
- Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Diseased Saphenous Vein GraftsJACC, 2006
- Percutaneous treatment of saphenous vein graft diseaseJACC, 2003
- Percutaneous Treatment of Saphenous Vein Bypass Graft ObstructionsCirculation, 2003
- Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemiaJACC, 2002
- Stent Placement Compared with Balloon Angioplasty for Obstructed Coronary Bypass GraftsNew England Journal of Medicine, 1997